Dr. Tyson Quy, M.D

NPI: 1447453071
Total Payments
$35,983
2024 Payments
$35,550
Companies
8
Transactions
80
Medicare Patients
520
Medicare Billing
$80,819

Payment Breakdown by Category

Consulting$35,550 (98.8%)
Food & Beverage$427.76 (1.2%)
Education$5.38 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $35,550 60 98.8%
Food and Beverage $427.76 18 1.2%
Education $5.38 2 0.0%

Top Paying Companies

Company Total Records Latest Year
CSL Plasma Inc. $35,550 60 $0 (2024)
Boehringer Ingelheim Pharmaceuticals, Inc. $163.64 3 $0 (2018)
Sunovion Pharmaceuticals Inc. $89.47 8 $0 (2017)
Allergan Inc. $81.10 4 $0 (2017)
AstraZeneca Pharmaceuticals LP $34.79 2 $0 (2018)
PFIZER INC. $30.11 1 $0 (2023)
Stryker Corporation $18.95 1 $0 (2017)
Lilly USA, LLC $15.08 1 $0 (2017)

Payment History by Year

Year Amount Transactions Top Company
2024 $35,550 60 CSL Plasma Inc. ($35,550)
2023 $30.11 1 PFIZER INC. ($30.11)
2018 $158.76 3 Boehringer Ingelheim Pharmaceuticals, Inc. ($123.97)
2017 $244.27 16 Sunovion Pharmaceuticals Inc. ($89.47)

All Payment Transactions

80 individual payment records from CMS Open Payments — Page 1 of 4

Date Company Product Nature Form Amount Type
12/18/2024 CSL Plasma Inc. Consulting Fee Cash or cash equivalent $750.00 General
12/11/2024 CSL Plasma Inc. Consulting Fee Cash or cash equivalent $600.00 General
12/11/2024 CSL Plasma Inc. Consulting Fee Cash or cash equivalent $600.00 General
12/04/2024 CSL Plasma Inc. Consulting Fee Cash or cash equivalent $600.00 General
11/20/2024 CSL Plasma Inc. Consulting Fee Cash or cash equivalent $600.00 General
11/13/2024 CSL Plasma Inc. Consulting Fee Cash or cash equivalent $600.00 General
11/13/2024 CSL Plasma Inc. Consulting Fee Cash or cash equivalent $450.00 General
11/06/2024 CSL Plasma Inc. Consulting Fee Cash or cash equivalent $600.00 General
11/06/2024 CSL Plasma Inc. Consulting Fee Cash or cash equivalent $300.00 General
10/30/2024 CSL Plasma Inc. Consulting Fee Cash or cash equivalent $600.00 General
10/23/2024 CSL Plasma Inc. Consulting Fee Cash or cash equivalent $450.00 General
10/16/2024 CSL Plasma Inc. Consulting Fee Cash or cash equivalent $600.00 General
10/16/2024 CSL Plasma Inc. Consulting Fee Cash or cash equivalent $150.00 General
10/09/2024 CSL Plasma Inc. Consulting Fee Cash or cash equivalent $300.00 General
10/09/2024 CSL Plasma Inc. Consulting Fee Cash or cash equivalent $150.00 General
10/02/2024 CSL Plasma Inc. Consulting Fee Cash or cash equivalent $600.00 General
10/02/2024 CSL Plasma Inc. Consulting Fee Cash or cash equivalent $600.00 General
10/02/2024 CSL Plasma Inc. Consulting Fee Cash or cash equivalent $300.00 General
09/25/2024 CSL Plasma Inc. Consulting Fee Cash or cash equivalent $600.00 General
09/25/2024 CSL Plasma Inc. Consulting Fee Cash or cash equivalent $300.00 General
09/18/2024 CSL Plasma Inc. Consulting Fee Cash or cash equivalent $600.00 General
09/11/2024 CSL Plasma Inc. Consulting Fee Cash or cash equivalent $600.00 General
09/04/2024 CSL Plasma Inc. Consulting Fee Cash or cash equivalent $600.00 General
09/04/2024 CSL Plasma Inc. Consulting Fee Cash or cash equivalent $600.00 General
08/28/2024 CSL Plasma Inc. Consulting Fee Cash or cash equivalent $600.00 General

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 8 220 226 $27,138 $13,004
2021 3 132 486 $64,100 $40,564
2020 4 168 372 $53,714 $27,251
Total Patients
520
Total Services
1,084
Medicare Billing
$80,819
Procedure Codes
15

All Medicare Procedures & Services

15 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 42 44 $7,114 $3,774 53.1%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 47 47 $7,332 $3,635 49.6%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 53 55 $6,076 $3,498 57.6%
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc Office 2023 17 17 $2,533 $854.76 33.7%
87428 Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza Office 2023 11 11 $2,200 $708.82 32.2%
87880 Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) Office 2023 18 18 $576.00 $291.60 50.6%
96372 Injection of drug or substance under skin or into muscle Office 2023 17 19 $1,007 $190.44 18.9%
81002 Urinalysis, manual test Office 2023 15 15 $300.00 $51.15 17.1%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2021 68 420 $52,500 $33,036 62.9%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2021 33 35 $7,725 $5,083 65.8%
99239 Hospital discharge day management, more than 30 minutes Facility 2021 31 31 $3,875 $2,445 63.1%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2020 78 241 $34,060 $17,876 52.5%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2020 24 27 $6,095 $3,989 65.4%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 37 74 $9,884 $2,903 29.4%
99239 Hospital discharge day management, more than 30 minutes Facility 2020 29 30 $3,675 $2,483 67.6%

About Dr. Tyson Quy, M.D

Dr. Tyson Quy, M.D is a Emergency Medicine healthcare provider based in Oklahoma City, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/10/2007. The National Provider Identifier (NPI) number assigned to this provider is 1447453071.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Tyson Quy, M.D has received a total of $35,983 in payments from pharmaceutical and medical device companies, with $35,550 received in 2024. These payments were reported across 80 transactions from 8 companies. The most common payment nature is "Consulting Fee" ($35,550).

As a Medicare-enrolled provider, Quy has provided services to 520 Medicare beneficiaries, totaling 1,084 services with total Medicare billing of $80,819. Data is available for 3 years (2020–2023), covering 15 distinct procedure/service records.

Practice Information

  • Specialty Emergency Medicine
  • Other Specialties Family Medicine
  • Location Oklahoma City, OK
  • Active Since 06/10/2007
  • Last Updated 01/16/2025
  • Taxonomy Code 207P00000X
  • Entity Type Individual
  • NPI Number 1447453071

Products in Payments

  • UTIBRON (Drug) $89.47
  • BYSTOLIC (Drug) $81.10
  • PAXLOVID (Drug) $30.11
  • STIOLTO (Drug) $23.83
  • AVIATOR (Device) $18.95
  • BEVESPI AEROSPHERE (Drug) $18.50
  • SYMBICORT (Drug) $16.29
  • SPIRIVA (Drug) $15.84
  • TRULICITY (Drug) $15.08

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Emergency Medicine Doctors in Oklahoma City